The Cannabis Business Advisors Launches DEA Compliance Platform
New software suite targets operators preparing for Schedule III registration requirements.
Close-up of a person examining a credit card authorization form inside an office setting.
Platform Targets Registration Workflow
The Cannabis Business Advisors' new platform automates DEA registration documentation, security protocols, and recordkeeping requirements for Schedule III cannabis handlers. The software suite includes pre-filled Form 225 templates, inventory tracking modules that meet DEA diversion-control standards, and audit-trail dashboards designed to satisfy federal inspectors.
The launch coincides with the DEA's opening of its registration portal for cannabis businesses following the rescheduling finalized in March 2026. Operators handling cannabis as a Schedule III controlled substance must register with the DEA and comply with manufacturing, distribution, and security requirements under 21 CFR Part 1301.
The Cannabis Business Advisors positioned the platform as a turnkey solution for the estimated 12,000 to 15,000 state-licensed cannabis businesses that'll need federal registration. Registration fees run $888 for manufacturers and $731 for distributors. Renewal cycles hit every three years.
Market Opportunity in Compliance Transition
The compliance-software market for cannabis is projected to grow from $340 million in 2025 to $1.2 billion by 2028 as operators layer federal requirements onto existing state systems. Competitors include Metrc, BioTrackTHC, and Leaf Logix, though none has released a DEA-specific registration module to date.
Bull case: The Cannabis Business Advisors captures early-mover advantage in a greenfield segment, with subscription revenue scaling as operators phase in federal compliance over the next 18 months. Sign 2,000 clients at an estimated $500 monthly subscription, and that's $12 million in annual recurring revenue.
Bear case? Execution risk. The platform's efficacy depends on real-time synchronization with DEA systems that remain untested at scale, and any software glitches during peak registration periods could erode customer trust and open the door for incumbents with deeper engineering resources.
What Operators Should Watch
DEA registration is a prerequisite for interstate commerce and banking access under the revised Controlled Substances Act framework. Operators that delay registration risk losing wholesale contracts with multistate operators and forfeiting access to Federal Reserve payment rails that unlock traditional banking.
Background checks are required for owners with more than 10% equity stakes. Site inspections, too. Security plans must detail physical safeguards against diversion. The Cannabis Business Advisors' platform includes a compliance calendar that flags deadlines 60 days in advance, a feature designed to prevent lapses that trigger enforcement actions.
For full background on DEA registration requirements and rescheduling timelines, see the CannIntel topic hub on DEA Registration and Rescheduling. The next signal to watch: DEA guidance on acceptable security protocols, expected by August 2026.
Frequently asked questions
What is DEA registration for cannabis businesses?
DEA registration is a federal requirement for businesses handling Schedule III cannabis. Operators must file Form 225, pass background checks, and implement security protocols meeting 21 CFR Part 1301 standards. Registration costs $888 for manufacturers and $731 for distributors, with three-year renewal cycles.
Why is DEA registration required now?
Cannabis was rescheduled from Schedule I to Schedule III in March 2026, subjecting it to Controlled Substances Act requirements for registered handlers. Registration is a prerequisite for interstate commerce, banking access, and federal tax deductions under revised IRS Code Section 280E.
How many cannabis businesses need DEA registration?
An estimated 12,000 to 15,000 state-licensed cannabis cultivators, manufacturers, and distributors will require DEA registration. The registration portal opened June 2026, with a phased rollout expected through December 2027.
What are the risks of delaying DEA registration?
Operators without DEA registration cannot engage in interstate commerce, access Federal Reserve payment systems, or claim standard business deductions. Delayed registration also risks enforcement actions, including cease-and-desist orders and civil penalties up to $10,000 per violation.
Who are the main competitors in cannabis compliance software?
Metrc, BioTrackTHC, and Leaf Logix dominate state-level compliance tracking. The Cannabis Business Advisors is the first to release a DEA-specific registration module, though incumbents are expected to launch competing products by Q4 2026.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business
Nebraska cultivator cleared to plant first legal medical marijuana crop
State regulators issued the first cultivation license, marking the operational launch of Nebraska's voter-approved medical cannabis program.
FINO Cannabis Opens First Florida Dispensary in Market Expansion Push
The multistate operator launches its inaugural Florida retail location as competition intensifies in the state's medical cannabis market.
New Report Finds Consumer Knowledge Gap Constraining Concentrates Growth
Higher Function and Lit survey reveals 62% of U.S. consumers lack confidence purchasing concentrates ahead of 7/10 holiday.
More from the newsroom
Virginia's $250 Public Marijuana Fine Draws Advocate Pushback
Reform groups challenge civil penalty structure as disproportionate to decriminalization intent under Va. Code § 4.1-600.
Marijuana Moment Petitions DEA Judge to Livestream Rescheduling Hearing
The news outlet filed a motion seeking public broadcast access to the administrative hearing on cannabis's Schedule III placement.
Minnesota Study Shows Medical Cannabis Improves Pain Patient Life Quality
State officials document significant gains in daily enjoyment among chronic pain patients enrolled in the medical program.